Project Details
Abstract
As the diet and living habits of people in Taiwan become westernized, the number of
diabetic patients in Taiwan has been kept increasing. Diabetes significantly increases the
risk for many other diseases such as cardiovascular and kidney diseases. Another example is
the impaired wound healing in diabetic patients and some severe cases may result in the limb
amputation. Currently, only becaplermin (recombinant human platelet-derived growth factor
homodimer of B chains, PDGF-BB, Regranex,), a very expensive standard therapy, is used to
improve the healing of diabetic foot. Nowadays, no other alternative drug with same
efficacy is available. The discovery of pepntadecapeptide PL 14736 from gastric juice was
first identified in 1993 which was later found to efficiently improve the healing of various
tissues or organ. However, very few studies have been performed to investigate the detailed
molecular mechanisms. The present study is aimed to further understand the potential
mechanisms underlying the beneficial effects of PL 146736 on improving the healing of
diabetic wounds. The study will first be focused on investigating the effects of PL 14736 on
angiognesis and the fibroblast functions including proliferation and migration. As we know
that the synthesis of pentadecapeptide is relatively simple and small dose ranged between ng-
μg/ml is already effective. The experimental results of this study will lead and shed light
on the understanding of PL 14736 efficacy and explore the future application of PL 14736
therapy to many other different diseases. This study will be carried out in three years:
The first year--to investigate the effects of PL 14736 on the in vivo and in vitro
angiogenesis and the gene expressions of pro-angiogenic factors;
The second year--to investigate the effects of PL 14736 on improving the wound
healing in diabetic mice and the function of endothelial progenitor cells in the blood;
The third year--to investigate the effects of PL 14736 on the proliferation and
migration of fibroblasts both in vivo and in vitro, and the expressions of growth-related
genes.
Project IDs
Project ID:PC9808-0537
External Project ID:NSC98-2320-B182-035-MY3
External Project ID:NSC98-2320-B182-035-MY3
Status | Finished |
---|---|
Effective start/end date | 01/08/09 → 31/07/10 |
Keywords
- pentadecapeptide PL 14736
- diabetes
- wound healing
- angiogenesis
- cell
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.